30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q13 Revenue: MAKO Surgical

$28.2MM, +19%

  • Procedures $16.3MM, +26%
  • Systems $8.2MM, flat
  • Service $3.6MM, +46%


  • 3,274 MAKOplasty procedures performed, +26% from prior year (3,125 domestic; 2,697 partial knees, +17%; 577 total hip arthroplasty/THA, +106%)
  • 10 RIO systems sold (8 domestic), including 1st commercial system in Turkey
  • 9 MAKOplasty THA applications sold; applications in field at 65% of installed base
  • Hip surgeon users are typically high-volume, experienced docs primarily using RIO for complex hip cases or younger, technologically-savvy surgeon
  • Launching THA version 2.1 in 3Q, featuring faster procedure time, better support for direct anterior approach:
    • 3D digital planning
    • Express femoral workflow
    • Less invasive tracking/improved fixation
    • Haptic boundaries 2x stronger during reaming, 4x stronger during impaction